Artivion, Inc. Stock News

Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.

Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Here is how Artivion (AORT) and Cencora (COR) have performed compared to their sector so far this year.

Small-cap stocks can be solid considerations for those who can handle a higher level of volatility. Analysts have recently become bullish on these three.

We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.

Here is how Artivion (AORT) and Astria Therapeutics, Inc. (ATXS) have performed compared to their sector so far this year.

Here is how Artivion (AORT) and Boston Scientific (BSX) have performed compared to their sector so far this year.

Artivion (AORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

The average of price targets set by Wall Street analysts indicates a potential upside of 30.7% in Artivion (AORT). While the effectiveness of this highly sought-after metric is questionable, the posit

Artivion, Inc. (AORT) Q4 2023 Earnings Call Transcript

Artivion (AORT) came out with quarterly earnings of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.13 per share. This compares to earnings of $0.10 per share a year ago.

Reports of various elected U.S. officials making significant, conveniently timed trades are not, unfortunately, rare. While much focus has been given to Nancy Pelosi and her husband – and indeed, th

In May 2022, Quiver Quantitative, an alternative data platform catering to retail investors, introduced a trading bot that mimics the stock purchases made by influential US politicians.

Largely thanks to the efforts of the online investor community, interesting, suspicious, and conveniently timed trades made by elected officials in the U.S. have come under increased scrutiny in recen

Artivion, Inc. (NYSE:AORT ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Laine Morgan - Gilmartin Group Pat Mackin - Chairman, President, and Chief Executive Offic